Owing to the loss of AQP4 in the tumor area, the exchange of CSF and ISF is decreased and the clearance of harmful solutes is limited in tumors, which has been confirmed in both Alzheimer’s disease and Parkinson’s disease (30, 49–51). This evidence concerns the gene AQP4 and early-onset autosomal dominant Alzheimer disease.